Oncology

Pathos AI Raises $237 Million in Series E Led by Bristol Myers Squibb at $3 Billion Valuation.

Bipsiq October 23, 2026

New York-based Pathos AI secured $237 million in Series E financing led by Bristol...

Hexagon Bio, a US-based biotechnology company developing novel antibody-drug conjugate therapies for cancer, raises $62 million in Series C funding.

Hexagon Bio Raises $62 Million in Series C Funding Led by The Column Group.

Bipsiq October 23, 2026

US-based biotechnology company Hexagon Bio has secured $62 million in Series C financing led...

Skopos Bio branding representing the Melbourne-based biotechnology startup developing targeted radiopharmaceutical therapies for cancer.

Skopos Bio Raises A$12 Million in Seed Funding to Advance Cancer Therapies

Bipsiq October 1, 2026

Melbourne-based Skopos Bio has secured A$12 million in seed funding to develop targeted radiopharmaceuticals...

Link Cell Therapies branding for the oncology biotechnology company developing logic-gated CAR-T therapies.

Link Cell Therapies Upsizes Series A to $90 Million

Bipsiq September 28, 2026

Link Cell Therapies has added $30 million to its Series A, bringing the round...

Molecular Targeting Technologies radiopharmaceutical research focused on targeted cancer therapies.

Molecular Targeting Technologies Receives $3.17 Million NCI Grant for Lung Cancer Radiopharmaceutical Program

Bipsiq September 22, 2026

MTTI has announced a five-year, $3.17 million National Cancer Institute grant supporting development of...

Thyme Care Raises Over $125 Million in Series E Led by Morgan Health

Bipsiq September 2, 2026

Thyme Care has raised more than $125 million in Series E financing led by...

N-Power Medicine branding for the oncology clinical research company's $32 million Series B financing announcement.

N-Power Medicine Closes $32 Million Series B to Expand Oncology Research Network

Bipsiq September 1, 2026

N-Power Medicine has closed a $32 million Series B financing round, adding Labcorp Venture...